Literature DB >> 3571263

The interaction of calmodulin with human erythrocyte spectrin. Inhibition of protein 4.1-stimulated actin binding.

J P Anderson, J S Morrow.   

Abstract

The functional significance of calmodulin binding to human erythrocyte spectrin has been investigated under native conditions. Both native calmodulin and calmodulin derivatized with the photoactivable cross-linker methyl 4-azidobenzimidate (azidocalmodulin) have been used. When azidocalmodulin is photolyzed in the presence of erythrocyte ghosts, ghost extracts, or purified protein, it cross-links predominately to the beta subunit of erythrocyte spectrin. This cross-linking is calcium-dependent, requires photolysis, and is inhibited by 100 microM trifluoperazine or unlabeled calmodulin. Calmodulin labeled spectrin exhibits a specific and non-calcium-dependent inhibition of its ability to bind actin, even in the presence of protein 4.1. Its ability to self-associate or to bind spectrin-depleted membrane vesicles is unperturbed. Native calmodulin also inhibits protein 4.1-stimulated spectrin-actin binding, but unlike that of covalently bound calmodulin, inhibition by the uncross-linked calmodulin requires calcium. The degree of inhibition of spectrin-actin-4.1 binding induced by native calmodulin is significant since 109 microM calmodulin inhibits over 63% of the spectrin-actin binding induced by 4.5 microM protein 4.1. These results demonstrate a specific effect of calmodulin on erythroid spectrin function and suggest that calmodulin may influence the binding of protein 4.1 and actin to spectrin within the cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571263

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  TRPing on the lung endothelium: calcium channels that regulate barrier function.

Authors:  Donna L Cioffi; Kevin Lowe; Diego F Alvarez; Christina Barry; Troy Stevens
Journal:  Antioxid Redox Signal       Date:  2009-04       Impact factor: 8.401

Review 2.  Role of the phosphorylation of red blood cell membrane proteins.

Authors:  P Boivin
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

3.  Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells.

Authors:  J G Conboy; J Chan; N Mohandas; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

4.  Spin-labeling studies of the conformation of the Ca(2+)-regulatory protein calmodulin in solution and bound to the membrane skeleton in erythrocyte ghosts: implications to transmembrane signaling.

Authors:  M A Yacko; D A Butterfield
Journal:  Biophys J       Date:  1992-08       Impact factor: 4.033

5.  Duchenne muscular dystrophy and dystrophin: sequence homology observations.

Authors:  A D Gurusinghe; M C Wilce; L Austin; M T Hearn
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

6.  Modulation of erythrocyte membrane material properties by Ca2+ and calmodulin. Implications for their role in regulation of skeletal protein interactions.

Authors:  Y Takakuwa; N Mohandas
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

7.  Calmodulin and wound healing in the coenocytic green alga Ernodesmis verticillata (Kützing) Børgesen: Ultrastructure of the cortical cytoskeleton and immunogold labeling.

Authors:  R H Goddard; J W La Claire
Journal:  Planta       Date:  1991-12       Impact factor: 4.116

8.  Synapsin I: an actin-bundling protein under phosphorylation control.

Authors:  T C Petrucci; J S Morrow
Journal:  J Cell Biol       Date:  1987-09       Impact factor: 10.539

9.  Erythrocyte adducin: a calmodulin-regulated actin-bundling protein that stimulates spectrin-actin binding.

Authors:  S M Mische; M S Mooseker; J S Morrow
Journal:  J Cell Biol       Date:  1987-12       Impact factor: 10.539

10.  Ankyrin binds to the 15th repetitive unit of erythroid and nonerythroid beta-spectrin.

Authors:  S P Kennedy; S L Warren; B G Forget; J S Morrow
Journal:  J Cell Biol       Date:  1991-10       Impact factor: 10.539

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.